PL449854A1 - Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water - Google Patents

Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water

Info

Publication number
PL449854A1
PL449854A1 PL449854A PL44985424A PL449854A1 PL 449854 A1 PL449854 A1 PL 449854A1 PL 449854 A PL449854 A PL 449854A PL 44985424 A PL44985424 A PL 44985424A PL 449854 A1 PL449854 A1 PL 449854A1
Authority
PL
Poland
Prior art keywords
drinking water
pharmaceutical composition
therapeutic
therapeutic drinking
producing
Prior art date
Application number
PL449854A
Other languages
Polish (pl)
Inventor
Piotr OKONIEWSKI
Original Assignee
Okoniewski Piotr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Okoniewski Piotr filed Critical Okoniewski Piotr
Priority to PL449854A priority Critical patent/PL449854A1/en
Priority to PCT/PL2024/050078 priority patent/WO2026063805A1/en
Publication of PL449854A1 publication Critical patent/PL449854A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/02—Acaricides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P7/00—Arthropodicides
    • A01P7/04—Insecticides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest kompozycja farmaceutyczna zawierająca co najmniej jeden związek izoksazoliny lub jego soli lub solwatu oraz farmaceutycznie dopuszczalny nośnik, podawana doustnie przez wodę pitną, zawierająca ester pochodzący z nasyconego lub nienasyconego alkoholu od CH3OH do C10H7-21OH oraz nasyconego, nienasyconego lub rozgałęzionego kwasu od HCOOH do C10H7-21COOH oraz środek powierzchniowo czynny w postaci rycynowego glicerolu makrogolu etoksylowanego od 30 do 50 cząsteczek tlenku etylenu. Przedmiotem zgłoszenia jest również lecznicza woda pitna, zawierająca tą kompozycję, zastosowanie kompozycji i wody oraz sposobu wytwarzania wody.The subject of the application is a pharmaceutical composition comprising at least one isoxazoline compound or a salt or solvate thereof and a pharmaceutically acceptable carrier, administered orally via drinking water, comprising an ester derived from a saturated or unsaturated alcohol from CH3OH to C10H7-21OH and a saturated, unsaturated or branched acid from HCOOH to C10H7-21COOH, and a surfactant in the form of ricinoleate macrogol glycerol ethoxylated with 30 to 50 ethylene oxide molecules. The subject of the application is also a therapeutic drinking water containing this composition, the use of the composition and water, and a method for producing the water.

PL449854A 2024-09-18 2024-09-18 Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water PL449854A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL449854A PL449854A1 (en) 2024-09-18 2024-09-18 Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water
PCT/PL2024/050078 WO2026063805A1 (en) 2024-09-18 2024-10-29 A pharmaceutical composition, medicated drinking water, their use and method of preparing medicated drinking water

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449854A PL449854A1 (en) 2024-09-18 2024-09-18 Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water

Publications (1)

Publication Number Publication Date
PL449854A1 true PL449854A1 (en) 2026-03-23

Family

ID=93939496

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449854A PL449854A1 (en) 2024-09-18 2024-09-18 Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water

Country Status (2)

Country Link
PL (1) PL449854A1 (en)
WO (1) WO2026063805A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130065846A1 (en) * 2011-09-12 2013-03-14 Mark D. Soll Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP3082867A1 (en) * 2013-12-20 2016-10-26 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2023037253A1 (en) * 2021-09-08 2023-03-16 Pi Industries Ltd Isoxazoline compounds and their use as pest control agents
WO2023221854A1 (en) * 2022-05-20 2023-11-23 天津瑞普生物技术股份有限公司 Anti-parasitic infection oral pharmaceutical preparation, method for preparing same, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082806B1 (en) * 2013-12-20 2021-05-12 Intervet International B.V. Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130065846A1 (en) * 2011-09-12 2013-03-14 Mark D. Soll Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
EP3082867A1 (en) * 2013-12-20 2016-10-26 Intervet International B.V. Isoxazoline compositions and use thereof in the prevention or treatment of parasite infestations in animals
WO2023037253A1 (en) * 2021-09-08 2023-03-16 Pi Industries Ltd Isoxazoline compounds and their use as pest control agents
WO2023221854A1 (en) * 2022-05-20 2023-11-23 天津瑞普生物技术股份有限公司 Anti-parasitic infection oral pharmaceutical preparation, method for preparing same, and use thereof

Also Published As

Publication number Publication date
WO2026063805A1 (en) 2026-03-26

Similar Documents

Publication Publication Date Title
DK0996429T3 (en) Solid solutions and solid dispersions in water heavily soluble drugs
KR920021139A (en) Pharmaceutical composition
JP2015521995A5 (en)
ES2523873T3 (en) Administration of a partial fatty acid oxidation inhibitor, such as ranolazine, for the treatment of diabetes
NO20025629L (en) Formulation
RU2010139958A (en) STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING DOCETSAXEL
CO5380014A1 (en) PHARMACEUTICAL FORMULATION FOR ORAL OR TOPIC ADMINISTRATION OF HYDROPHOBIC COMPOUNDS THAT DOES NOT FRAME EMULSION
JPWO2005044276A1 (en) Prostaglandin-containing pharmaceutical composition
PL449854A1 (en) Pharmaceutical composition, therapeutic drinking water, their use, and method for producing therapeutic drinking water
JP3802105B2 (en) Diclofenac sodium-containing emulsified external preparation
TWI716394B (en) External pharmaceutical composition
RU2011150246A (en) OIL-IN-WATER EMULSION OF MOMENTASON AND PROPYLENE GLYCOL
EP0440811B1 (en) Composition for percutaneous administration
PT1517682E (en) Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
TW201630606A (en) GALENIC formulation comprising a topical drug
KR950003611B1 (en) Antimycotic external lmidazole preparations
AU2007316482A1 (en) Method of treating asthma, allergic rhinitis, and skin disorders
JP2019123755A (en) Aqueous composition
JP5217530B2 (en) Suppository
JP2018534358A (en) Treatment of skin disorders by topical administration of VEGF inhibitors
JP2008143894A (en) Suppository
RU2021136865A (en) TREATMENT OF SKIN FORM OF LUPUUS RED
EP4114358A1 (en) Topical pharmaceutical formulations of a cyclic depsipeptide
JP2024507852A (en) Method for treating non-alcoholic steatohepatitis with SCD1 inhibitors
AR033771A1 (en) PHARMACEUTICAL COMPOSITION